CKD Pharmacotherapy Flashcards
Chronic CKD =
> 3 months
RASS inhibition is
Renoprotective
BP decrease Albuminuria decreases
Prevent progression via
BP management/RAAS interruption
Protein intake
Glycemic control
Salt intake
Treat to
Urine albumin excretion less than 39 or BP is >140 or >90
Non-DM treat to
Urine albumin excretion of 30-300mg/24h OR >300mg/24h
BP consistently >130 or >80
-ACEi or ARB recommended
DM treat to
Urine albumin >30mg/24h
BP consistently >130 or >80
-ACEi or ARB recommended
ACEi/ARB dosing
Low dose, then titrate at 4 weeks
Increase until proteinuria decrease 30-50% or side effects
ACEi/ARB dosing
Low dose, then titrate at 4 weeks
Increase until proteinuria decrease 30-50% or side effects
Non-DHP CCB
May been beneficial for proteinuria
Diltiazem and verapamil
MDRD
Modification of Diet in Renal Disease
Restriction of protein and phosphorus
Systemic BP reduction
Most for Non-DM pts
Protein Restriction
0.8g/kg/d for GFR less than 30
Avoid >1.3g/kg/d in adults at high risk for CKD progression
DM CKD
A1c: ~7.0
>7.0 if co-morbidities, limited life expectancy, hypoglycemia
Diabetes Control and Complication Trial (DCCT)
Decreased incidence of microalbuminuria and albuminuria
Salt intake
Less than 2 grams per day
High sodium intake:
Increases BP, proteinuria
Induces glomerular hyperfiltration
Blunts RAAS blockade